We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.35%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$113M
AUM Growth
-$2.14M
Cap. Flow
-$5.51M
Cap. Flow %
-4.87%
Top 10 Hldgs %
14.17%
Holding
280
New
34
Increased
61
Reduced
100
Closed
19

Top Buys

Rank Stock Value
1
FNCL icon
Fidelity MSCI Financials Index ETF
FNCL
+$1.46M
2
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$1.13M
3
MNOV icon
MediciNova
MNOV
+$969K
4
ADVM
Adverum Biotechnologies
ADVM
+$866K
5
CLSD
Clearside Biomedical
CLSD
+$856K

Top Sells

Rank Stock Value
1
FTEC icon
Fidelity MSCI Information Technology Index ETF
FTEC
+$2.78M
2
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
+$1.32M
3
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$1.22M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$1.01M
5
AVXS
AveXis, Inc. Common Stock
AVXS
+$938K

Sector Composition

Rank Sector Weight
1 Healthcare 77.9%
2 Financials 0.8%
3 Technology 0.58%
4 Consumer Discretionary 0.4%
5 Energy 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUMO
276
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-10,061
Closed -$656K
JNCE
277
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-58,867
Closed -$1.32M
CALA
278
DELISTED
Calithera Biosciences, Inc
CALA
– –
-4,436
Closed -$559K
TTPH
279
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-6,546
Closed -$402K
AVXS
280
DELISTED
AveXis, Inc. Common Stock
AVXS
– –
-7,590
Closed -$938K
8 9 10 11
12

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q2 2018 Portfolio in Review

As of Q2 2018, Virtus ETF Advisers held 280 positions worth $113M, down 1.9% from $115M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Virtus ETF Advisers withdrew a net $5.51M in Q2 2018, closing 19 positions and reducing 100 holdings. Its most notable exit was Jounce Therapeutics, Inc. Common Stock, an estimated $1.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 79% a quarter earlier, followed by Financials and Technology.

Against the trend, Virtus ETF Advisers opened a new position in Fidelity MSCI Financials Index ETF worth $1.41M.

  • Virtus ETF Advisers's largest Q2 2018 buy was Fidelity MSCI Financials Index ETF: 35,927 shares worth $1.41M.
  • Virtus ETF Advisers added most to iShares 20+ Year Treasury Bond ETF in Q2 2018, an estimated $1.13M increase.
  • Virtus ETF Advisers's biggest Q2 2018 reduction was Fidelity MSCI Information Technology Index ETF, cutting an estimated $2.78M.
  • Virtus ETF Advisers fully exited Jounce Therapeutics, Inc. Common Stock in Q2 2018, selling an estimated $1.32M.
  • Virtus ETF Advisers's ten largest holdings make up 14% of its $113M portfolio in Q2 2018.
  • Virtus ETF Advisers opened 34 new positions and closed 19 in Q2 2018.
  • Virtus ETF Advisers's portfolio value fell 1.9% quarter-over-quarter to $113M.

Based on Virtus ETF Advisers's 13F filing for Q2 2018, filed 10 Aug 2018.